Felix J. Hartmann
Max Eyth Str. 2
Kiel, SH 24118, Germany
Kiel, SH 24118, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
FGFR2 fusion-driven cholangiocarcinoma is characterized by a distinct neutrophil-enriched tumor microenvironment in a syngeneic murine model.
Journal: JHEP reports : innovation in hepatology
Published: October 10, 2025
Spatial Immunometabolism: Integrating Technologies to Decode Cellular Metabolism in Tissues.
Journal: European journal of immunology
Published: June 30, 2025
Temporal and spatial composition of the tumor microenvironment predicts response to immune checkpoint inhibition in metastatic TNBC.
Journal: Nature cancer
Published: April 03, 2025
DHODH as a Targetable Metabolic Achilles' Heel for chemo-resistant B-ALL.
Journal: Blood
Published: March 20, 2025
DHODH as a targetable metabolic Achilles' heel for chemotherapy-resistant B-ALL.
Journal: Blood
Published: March 20, 2025
Uridine Metabolism as a Targetable Metabolic Achilles' Heel for chemo-resistant B-ALL.
Journal: bioRxiv : the preprint server for biology
Published: February 20, 2025
Temporal and spatial composition of the tumor microenvironment predicts response to immune checkpoint inhibition.
Journal: bioRxiv : the preprint server for biology
Published: February 20, 2025
Isolation of a tumor neoantigen specific CD8+ TCR from a skin biopsy of a vaccination site.
Journal: Oncoimmunology
Published: February 04, 2025
A microenvironment-determined risk continuum refines subtyping in meningioma and reveals determinants of machine learning-based tumor classification.
Journal: Nature genetics
Published: October 30, 2024
A call for accessible tools to unlock single-cell immunometabolism research.
Journal: Nature metabolism
Published: April 11, 2024
Learning tissue representation by identification of persistent local patterns in spatial omics data.
Learning tissue representation by identification of persistent local patterns in spatial omics data.
Journal: Nature communications
Published: March 26, 2024
Activated ATF6α is a hepatic tumour driver restricting immunosurveillance.
Journal: Nature
Published: October 05, 2023
Last Updated: 09/26/2026